Are Anuh Pharma latest results good or bad?

Anuh Pharma has released its financial results for the quarter ending March 2025, which show a mixed operational landscape. The company reported net sales of Rs 198.14 crore, marking the highest figure in the last five quarters and reflecting a growth of 26.4% compared to the average net sales from the previous four quarters. Additionally, profit before tax (PBT) reached Rs 15.88 crore, indicating a growth of 20.8% over the average PBT from the previous four quarters.
However, the company faced challenges with profit after tax (PAT) for the latest six months, which stood at Rs 22.80 crore, showing a significant decline of 33.86% year on year. This decline in PAT raises concerns regarding Anuh Pharma's financial health as it continues to navigate its operational challenges.

In terms of quarterly performance, Anuh Pharma's net sales demonstrated a growth of 24.22% compared to the previous quarter, while standalone net profit also saw a growth of 20.50%. The operating profit margin remained relatively stable, reflecting a slight change.

Furthermore, it is noted that Anuh Pharma experienced an adjustment in its evaluation over the last three months. Overall, while there are positive developments in sales and profit before tax, the decline in profit after tax suggests ongoing challenges that the company must address.